Submitted by Anonymous (not verified) on 5 March 2026 - 14:52
Human medicines European public assessment report (EPAR): Toujeo (previously Optisulin), insulin glargine, Date of authorisation: 26/06/2000, Revision: 38, Status: Authorised
Source: